3N4-13565-44640
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 900 / CA
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Dose 1 — Pfizer-BioNTech
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-04
Registered in v-safe
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-19
-
2021-05-07
Survey response — 3 months, dose 2MedDRA: Dry eye, Paraesthesia oral — Feeling: GoodFree text: Gritty sensation under tongue, followed by painless white spots that developed into painful red spots over a period of 3 weeks. Associated with dry eyes with scant mucoid discharge.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Aphonia, Cough, Headache, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sore throat and lost voice for 2 weeks after sexual encounter. Two days of cough from post-nasal drip. One day of headache. No fever. Thought it was pharyngeal gonorrhea but swab came back negative. Did not test for COVID.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-04
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — 3 months, dose 2
Symptoms: Gritty sensation under tongue, followed by painless white spots that developed into painful red spots over a period of 3 weeks. Associated with dry eyes with scant mucoid discharge.
Release 9 — 6 months, dose 2
Symptoms: Sore throat and lost voice for 2 weeks after sexual encounter. Two days of cough from post-nasal drip. One day of headache. No fever. Thought it was pharyngeal gonorrhea but swab came back negative. Did not test for COVID.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphonia | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Dry eye | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Paraesthesia oral | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release